Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1

Lixin Zheng1, Nicolas Bidere, David Staudt

  • 1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH, 9000 Rockville Pike, 10/11D09, Bethesda, MD 20892, USA. lzheng@niaid.nih.gov

Insights

Tumor necrosis factor receptor 1 (TNFR1) signaling involves TRADD and RIP1 proteins. These proteins compete to determine cell fate, initiating either apoptosis or necrosis via distinct pathways.

Area of Science:

  • Cellular biology
  • Immunology
  • Molecular signaling

Background:

  • Tumor necrosis factor receptor 1 (TNFR1) triggers diverse cellular outcomes, including apoptosis, necrosis, and NF-kappaB activation.
  • The TNFR-associated death domain (TRADD) protein is hypothesized as a key mediator of TNFR1 signaling.
  • Lack of TRADD-deficient cells hindered direct analysis of its role in mature immune cells.

Purpose of the Study:

  • To investigate the specific roles of TRADD and RIP1 in TNFR1-mediated cellular responses.
  • To elucidate the mechanism by which TNFR1 signaling pathways diverge to induce distinct cell death programs.

Main Methods:

  • Small interfering RNA (siRNA) was used to silence TRADD expression in cells.
  • Analysis of TNFR1-initiated signaling pathways, including NF-kappaB activation, apoptosis, and necrosis.
  • Investigated the competitive recruitment of TRADD and RIP1 to the TNFR1 signaling complex.

Main Results:

  • TRADD is essential for TNFR1-induced NF-kappaB activation and caspase-8-dependent apoptosis.
  • TRADD is dispensable for TNFR1-initiated, RIP1-dependent necrotic cell death.
  • TRADD and RIP1 compete for binding to TNFR1, directing distinct downstream signaling events.

Conclusions:

  • TNFR1 signaling diverges at the level of TRADD and RIP1 recruitment.
  • These two proteins act as competing transducers, dictating cell fate decisions.
  • TRADD and RIP1 independently control NF-kappaB activation, apoptosis, and nonapoptotic cell death pathways.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...